In clinical trials, researchers found Yeztugo to be highly effective as a twice-yearly form of pre-exposure prophylaxis.

The Food and Drug Administration has approved a new drug that could prevent HIV infections with just two shots every year and ...

“This is a historic day in the decades-long fight against HIV,” Gilead CEO Daniel O’Day said in the company’s announcement.

The Food and Drug Administration approved the preventative use of lenacapavir, made by Gilead Sciences, on Wednesday. Experts ...

Gilead's CEO says he's committed to making sure people around the world can get his firm's new HIV prevention shot Yeztugo.

But the Trump administration’s cuts to HIV programs in the U.S. and abroad could undermine the drug’s rollout.

Acyclovir is a generic prescription drug that’s used to treat certain viral infections. Acyclovir comes as an oral tablet. Acyclovir oral tablet is only available as a generic drug. It doesn’t ...

Its solution was to refile the drug under a different brand name and now, a year later, odevixibat has a second positive opinion from the CHMP for ALGS under the new Kayfanda brand. Its orphan ...

The US FDA has approved lenacapvir, sold under the brand name Yeztugo, as the first preventive treatment against HIV. It is a ...

Based on the result, Prilenia has speculated that the drug’s effect on the main endpoint was reduced by the use of neuroleptic medications and VMAT2 inhibitor drugs used to control the ...